» Articles » PMID: 35805153

Proteomics, Phosphoproteomics and Mirna Analysis of Circulating Extracellular Vesicles Through Automated and High-Throughput Isolation

Overview
Journal Cells
Publisher MDPI
Date 2022 Jul 9
PMID 35805153
Authors
Affiliations
Soon will be listed here.
Abstract

Extracellular vesicles (EVs) play an important role in the diagnosis and treatment of diseases because of their rich molecular contents involved in intercellular communication, regulation, and other functions. With increasing efforts to move the field of EVs to clinical applications, the lack of a practical EV isolation method from circulating biofluids with high throughput and good reproducibility has become one of the biggest barriers. Here, we introduce a magnetic bead-based EV enrichment approach (EVrich) for automated and high-throughput processing of urine samples. Parallel enrichments can be performed in 96-well plates for downstream cargo analysis, including EV characterization, miRNA, proteomics, and phosphoproteomics analysis. We applied the instrument to a cohort of clinical urine samples to achieve reproducible identification of an average of 17,000 unique EV peptides and an average of 2800 EV proteins in each 1 mL urine sample. Quantitative phosphoproteomics revealed 186 unique phosphopeptides corresponding to 48 proteins that were significantly elevated in prostate cancer patients. Among them, multiple phosphoproteins were previously reported to associate with prostate cancer. Together, EVrich represents a universal, scalable, and simple platform for EV isolation, enabling downstream EV cargo analyses for a broad range of research and clinical applications.

Citing Articles

The new advance of exosome-based liquid biopsy for cancer diagnosis.

Tang H, Yu D, Zhang J, Wang M, Fu M, Qian Y J Nanobiotechnology. 2024; 22(1):610.

PMID: 39380060 PMC: 11463159. DOI: 10.1186/s12951-024-02863-0.


Proteomic Profiling of Extracellular Vesicles Isolated from Plasma and Peritoneal Exudate in Mice Induced by Crude Venom and Its Purified Cysteine-Rich Secretory Protein (Css-CRiSP).

Reyes A, Hatcher J, Salazar E, Galan J, Iliuk A, Sanchez E Toxins (Basel). 2023; 15(7).

PMID: 37505703 PMC: 10467150. DOI: 10.3390/toxins15070434.


PhosY-secretome profiling combined with kinase-substrate interaction screening defines active c-Src-driven extracellular signaling.

Backe S, Votra S, Stokes M, Sebestyen E, Castelli M, Torielli L Cell Rep. 2023; 42(6):112539.

PMID: 37243593 PMC: 10569185. DOI: 10.1016/j.celrep.2023.112539.


Proteomic Research of Extracellular Vesicles in Clinical Biofluid.

Fan S, Poetsch A Proteomes. 2023; 11(2).

PMID: 37218923 PMC: 10204453. DOI: 10.3390/proteomes11020018.


Extracellular vesicle proteomics and phosphoproteomics identify pathways for increased risk in patients hospitalized with COVID-19 and type 2 diabetes mellitus.

Nunez Lopez Y, Iliuk A, Casu A, Parikh A, Smith J, Corbin K Diabetes Res Clin Pract. 2023; 197:110565.

PMID: 36736734 PMC: 9890887. DOI: 10.1016/j.diabres.2023.110565.


References
1.
Luga V, Zhang L, Viloria-Petit A, Ogunjimi A, Inanlou M, Chiu E . Exosomes mediate stromal mobilization of autocrine Wnt-PCP signaling in breast cancer cell migration. Cell. 2012; 151(7):1542-56. DOI: 10.1016/j.cell.2012.11.024. View

2.
Pang X, Xie R, Zhang Z, Liu Q, Wu S, Cui Y . Identification of SPP1 as an Extracellular Matrix Signature for Metastatic Castration-Resistant Prostate Cancer. Front Oncol. 2019; 9:924. PMC: 6760472. DOI: 10.3389/fonc.2019.00924. View

3.
Urabe F, Kosaka N, Ito K, Kimura T, Egawa S, Ochiya T . Extracellular vesicles as biomarkers and therapeutic targets for cancer. Am J Physiol Cell Physiol. 2019; 318(1):C29-C39. DOI: 10.1152/ajpcell.00280.2019. View

4.
Wu X, Li L, Iliuk A, Tao W . Highly Efficient Phosphoproteome Capture and Analysis from Urinary Extracellular Vesicles. J Proteome Res. 2018; 17(9):3308-3316. PMC: 7236337. DOI: 10.1021/acs.jproteome.8b00459. View

5.
Sharma P, Ludwig S, Muller L, Hong C, Kirkwood J, Ferrone S . Immunoaffinity-based isolation of melanoma cell-derived exosomes from plasma of patients with melanoma. J Extracell Vesicles. 2018; 7(1):1435138. PMC: 5827723. DOI: 10.1080/20013078.2018.1435138. View